Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Hair, Alan"'
Autor:
Pellicano, Francesca, Park, Laura *, Hopcroft, Lisa E.M. *, Shah, Mansi M., Jackson, Lorna, Scott, Mary T., Clarke, Cassie J., Sinclair, Amy, Abraham, Sheela A., Hair, Alan, Helgason, G. Vignir, Aspinall-O'Dea, Mark, Bhatia, Ravi, Leone, Gustavo, Kranc, Kamil R., Whetton, Anthony D., Holyoake, Tessa L.
Publikováno v:
In Blood 5 April 2018 131(14):1532-1544
Autor:
Tarafdar, Anuradha, Hopcroft, Lisa E.M., Gallipoli, Paolo, Pellicano, Francesca, Cassels, Jennifer, Hair, Alan, Korfi, Koorosh, Jørgensen, Heather G., Vetrie, David, Holyoake, Tessa L., Michie, Alison M.
Publikováno v:
In Blood 12 January 2017 129(2):199-208
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhang, Bin, Ho, Yin Wei, Huang, Qin, Maeda, Takahiro, Lin, Allen, Lee, Sung-uk, Hair, Alan, Holyoake, Tessa L., Huettner, Claudia, Bhatia, Ravi
Publikováno v:
In Cancer Cell 17 April 2012 21(4):577-592
Autor:
Mitchell, Rebecca, Hopcroft, Lisa, Baquero, Pablo, Allan, Elaine, Hewit, Kay, James, Daniel, Hamilton, Graham, Mukhopadhyay, Arunima, O’Prey, Jim, Hair, Alan, Melo, Junia, Chan, Edmond, Ryan, Kevin, Maguer-Satta, Veronique, Druker, Brian, Clark, Richard, Mitra, Subir, Herzyk, Pawel, Nicolini, Franck, Salomoni, Paolo, Shanks, Emma, Calabretta, Bruno, Holyoake, Tessa, Helgason, G Vignir
Publikováno v:
JNCI: Journal of the National Cancer Institute
JNCI: Journal of the National Cancer Institute, Oxford University Press (OUP), 2018, 110 (5), pp.467-478. ⟨10.1093/jnci/djx236⟩
JNCI Journal of the National Cancer Institute
JNCI: Journal of the National Cancer Institute, Oxford University Press (OUP), 2018, 110 (5), pp.467-478. ⟨10.1093/jnci/djx236⟩
JNCI Journal of the National Cancer Institute
Background Imatinib and second-generation tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib have statistically significantly improved the life expectancy of chronic myeloid leukemia (CML) patients; however, resistance to TKIs remains a major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7c80596c86377d3eb4fcc5fe73a51405
https://hal.archives-ouvertes.fr/hal-02363287
https://hal.archives-ouvertes.fr/hal-02363287
Autor:
Mitchell, Rebecca, Hopcroft, Lisa E M, Baquero, Pablo, Allan, Elaine K, Hewit, Kay, James, Daniel, Hamilton, Graham, Mukhopadhyay, Arunima, O'Prey, Jim, Hair, Alan, Melo, Junia V, Chan, Edmond, Ryan, Kevin M, Maguer-Satta, Véronique, Druker, Brian J, Clark, Richard E, Mitra, Subir, Herzyk, Pawel, Nicolini, Franck E, Salomoni, Paolo, Helgason, G Vignir
Background: Imatinib and second-generation tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib have statistically significantly improved the life expectancy of chronic myeloid leukemia (CML) patients; however, resistance to TKIs remains a major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::853a8c8084423b21e4bdf1fc88bdd782
https://strathprints.strath.ac.uk/62758/1/Mitchell_etal_JNCI_2017_Targeting_BCR_ABL_independent_TKI_resistance_in_chronic_myeloid_leukemia.pdf
https://strathprints.strath.ac.uk/62758/1/Mitchell_etal_JNCI_2017_Targeting_BCR_ABL_independent_TKI_resistance_in_chronic_myeloid_leukemia.pdf
Publikováno v:
In Journal of the American College of Surgeons 2001 193(2):125-129
Publikováno v:
In Journal of the American College of Surgeons 1999 189(3):269-273
Autor:
Todd, D. B., Findlay, George, Warwick, Jonathan, Handel, J., Craft, T. M., Cook, Brian, Sarmah, Anita, Graham, Colin A., Hair, Alan
Publikováno v:
BMJ: British Medical Journal, 1995 May . 310(6989), 1265-1266.
Externí odkaz:
https://www.jstor.org/stable/29727276
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.